Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept in Children and Adolescents With Active Polyarticular JRA
NCT00095173Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2003
- Primary completion
- Jun 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 11
01
Overview
A Phase 3 trial of abatacept in juvenile idiopathic arthritis (JIA), sponsored by Bristol Myers Squibb. Started Dec 2003; status: completed.
02
Drugs
abatacept
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on NCT00095173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095173.